Molecular response to hypericin-induced photodamage

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Hypericin (Hyp) is a natural photosensitizer used in photodynamic therapy (PDT).
• In PDT, Hypericin accumulates in tumor tissue and generates reactive oxygen species upon light activation to destroy cancer cells.

Purpose of the Study:

• To elucidate the molecular mechanisms and cellular endpoints following Hypericin-PDT.
• To understand how different PDT protocols influence cellular fate: biostimulation, repair, autophagy, apoptosis, or necrosis.

Main Methods:

• Analysis of molecular biological mechanisms.
• Investigation of cellular signaling pathways (p38, JNK, ER-stress).
• Assessment of cellular responses based on PDT parameters and cellular state.

Main Results:

• Low-dose Hyp-PDT can stimulate proliferation via p38/JNK survival pathways.
• Higher doses activate stress responses (ER-stress, Ca2+ disruption), leading to apoptosis or autophagic cell death.
• Necrosis occurs under severe damage, low energy, or compromised cell membranes.

Conclusions:

• Cellular response to Hypericin-PDT is dose-dependent and context-specific.
• Survival pathways mediate low-dose effects, while stress-induced apoptosis/autophagy dominate at higher doses.
• PDT protocol, photosensitizer localization, and cellular energy levels dictate the final cellular outcome.